Global and Japan Spinal Devices and Biologics Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Spinal Devices and Biologics Product Introduction
1.2 Market Segments
1.3 Key Spinal Devices and Biologics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Spinal Devices and Biologics Market Size Growth Rate by Type
1.4.2 Spinal Fusion & Fixation
1.4.3 Motion Preservation
1.4.4 Non-Fusion Technologies
1.4.5 Fracture Treatment
1.4.6 Other
1.5 Market by Application
1.5.1 Global Spinal Devices and Biologics Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Spinal Devices and Biologics Market Size, Estimates and Forecasts
2.1.1 Global Spinal Devices and Biologics Revenue 2015-2026
2.1.2 Global Spinal Devices and Biologics Sales 2015-2026
2.2 Global Spinal Devices and Biologics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Spinal Devices and Biologics Historical Market Size by Region (2015-2020)
2.3.1 Global Spinal Devices and Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Spinal Devices and Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Spinal Devices and Biologics Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Spinal Devices and Biologics Sales Forecast by Region (2021-2026)
2.4.2 Global Spinal Devices and Biologics Revenue Forecast by Region (2021-2026)
3 Global Spinal Devices and Biologics Competitor Landscape by Players
3.1 Global Top Spinal Devices and Biologics Sales by Manufacturers
3.1.1 Global Spinal Devices and Biologics Sales by Manufacturers (2015-2020)
3.1.2 Global Spinal Devices and Biologics Sales Market Share by Manufacturers (2015-2020)
3.2 Global Spinal Devices and Biologics Manufacturers by Revenue
3.2.1 Global Spinal Devices and Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Global Spinal Devices and Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Spinal Devices and Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Spinal Devices and Biologics Revenue in 2019
3.2.5 Global Spinal Devices and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Spinal Devices and Biologics Price by Manufacturers
3.4 Global Spinal Devices and Biologics Manufacturing Base Distribution, Product Types
3.4.1 Spinal Devices and Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Spinal Devices and Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Spinal Devices and Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Spinal Devices and Biologics Market Size by Type (2015-2020)
4.1.1 Global Spinal Devices and Biologics Sales by Type (2015-2020)
4.1.2 Global Spinal Devices and Biologics Revenue by Type (2015-2020)
4.1.3 Spinal Devices and Biologics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Spinal Devices and Biologics Market Size Forecast by Type (2021-2026)
4.2.1 Global Spinal Devices and Biologics Sales Forecast by Type (2021-2026)
4.2.2 Global Spinal Devices and Biologics Revenue Forecast by Type (2021-2026)
4.2.3 Spinal Devices and Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Spinal Devices and Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Spinal Devices and Biologics Market Size by Application (2015-2020)
5.1.1 Global Spinal Devices and Biologics Sales by Application (2015-2020)
5.1.2 Global Spinal Devices and Biologics Revenue by Application (2015-2020)
5.1.3 Spinal Devices and Biologics Price by Application (2015-2020)
5.2 Spinal Devices and Biologics Market Size Forecast by Application (2021-2026)
5.2.1 Global Spinal Devices and Biologics Sales Forecast by Application (2021-2026)
5.2.2 Global Spinal Devices and Biologics Revenue Forecast by Application (2021-2026)
5.2.3 Global Spinal Devices and Biologics Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Spinal Devices and Biologics Market Size YoY Growth 2015-2026
6.1.1 Japan Spinal Devices and Biologics Sales YoY Growth 2015-2026
6.1.2 Japan Spinal Devices and Biologics Revenue YoY Growth 2015-2026
6.1.3 Japan Spinal Devices and Biologics Market Share in Global Market 2015-2026
6.2 Japan Spinal Devices and Biologics Market Size by Players (International and Local Players)
6.2.1 Japan Top Spinal Devices and Biologics Players by Sales (2015-2020)
6.2.2 Japan Top Spinal Devices and Biologics Players by Revenue (2015-2020)
6.3 Japan Spinal Devices and Biologics Historic Market Review by Type (2015-2020)
6.3.1 Japan Spinal Devices and Biologics Sales Market Share by Type (2015-2020)
6.3.2 Japan Spinal Devices and Biologics Revenue Market Share by Type (2015-2020)
6.3.3 Japan Spinal Devices and Biologics Price by Type (2015-2020)
6.4 Japan Spinal Devices and Biologics Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Spinal Devices and Biologics Sales Forecast by Type (2021-2026)
6.4.2 Japan Spinal Devices and Biologics Revenue Forecast by Type (2021-2026)
6.4.3 Japan Spinal Devices and Biologics Price Forecast by Type (2021-2026)
6.5 Japan Spinal Devices and Biologics Historic Market Review by Application (2015-2020)
6.5.1 Japan Spinal Devices and Biologics Sales Market Share by Application (2015-2020)
6.5.2 Japan Spinal Devices and Biologics Revenue Market Share by Application (2015-2020)
6.5.3 Japan Spinal Devices and Biologics Price by Application (2015-2020)
6.6 Japan Spinal Devices and Biologics Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Spinal Devices and Biologics Sales Forecast by Application (2021-2026)
6.6.2 Japan Spinal Devices and Biologics Revenue Forecast by Application (2021-2026)
6.6.3 Japan Spinal Devices and Biologics Price Forecast by Application (2021-2026)
7 North America
7.1 North America Spinal Devices and Biologics Market Size YoY Growth 2015-2026
7.2 North America Spinal Devices and Biologics Market Facts & Figures by Country
7.2.1 North America Spinal Devices and Biologics Sales by Country (2015-2020)
7.2.2 North America Spinal Devices and Biologics Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Spinal Devices and Biologics Market Size YoY Growth 2015-2026
8.2 Europe Spinal Devices and Biologics Market Facts & Figures by Country
8.2.1 Europe Spinal Devices and Biologics Sales by Country
8.2.2 Europe Spinal Devices and Biologics Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Spinal Devices and Biologics Market Size YoY Growth 2015-2026
9.2 Asia Pacific Spinal Devices and Biologics Market Facts & Figures by Country
9.2.1 Asia Pacific Spinal Devices and Biologics Sales by Region (2015-2020)
9.2.2 Asia Pacific Spinal Devices and Biologics Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Spinal Devices and Biologics Market Size YoY Growth 2015-2026
10.2 Latin America Spinal Devices and Biologics Market Facts & Figures by Country
10.2.1 Latin America Spinal Devices and Biologics Sales by Country
10.2.2 Latin America Spinal Devices and Biologics Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Spinal Devices and Biologics Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Spinal Devices and Biologics Market Facts & Figures by Country
11.2.1 Middle East and Africa Spinal Devices and Biologics Sales by Country
11.2.2 Middle East and Africa Spinal Devices and Biologics Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Nuvasive
12.1.1 Nuvasive Corporation Information
12.1.2 Nuvasive Description and Business Overview
12.1.3 Nuvasive Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Nuvasive Spinal Devices and Biologics Products Offered
12.1.5 Nuvasive Recent Development
12.2 Orthofix International
12.2.1 Orthofix International Corporation Information
12.2.2 Orthofix International Description and Business Overview
12.2.3 Orthofix International Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Orthofix International Spinal Devices and Biologics Products Offered
12.2.5 Orthofix International Recent Development
12.3 Exactech
12.3.1 Exactech Corporation Information
12.3.2 Exactech Description and Business Overview
12.3.3 Exactech Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Exactech Spinal Devices and Biologics Products Offered
12.3.5 Exactech Recent Development
12.4 Wright Medical Group
12.4.1 Wright Medical Group Corporation Information
12.4.2 Wright Medical Group Description and Business Overview
12.4.3 Wright Medical Group Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Wright Medical Group Spinal Devices and Biologics Products Offered
12.4.5 Wright Medical Group Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Spinal Devices and Biologics Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Zimmer Biomet
12.6.1 Zimmer Biomet Corporation Information
12.6.2 Zimmer Biomet Description and Business Overview
12.6.3 Zimmer Biomet Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Zimmer Biomet Spinal Devices and Biologics Products Offered
12.6.5 Zimmer Biomet Recent Development
12.7 Globus Medical
12.7.1 Globus Medical Corporation Information
12.7.2 Globus Medical Description and Business Overview
12.7.3 Globus Medical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Globus Medical Spinal Devices and Biologics Products Offered
12.7.5 Globus Medical Recent Development
12.8 K2M
12.8.1 K2M Corporation Information
12.8.2 K2M Description and Business Overview
12.8.3 K2M Sales, Revenue and Gross Margin (2015-2020)
12.8.4 K2M Spinal Devices and Biologics Products Offered
12.8.5 K2M Recent Development
12.9 Medtronic
12.9.1 Medtronic Corporation Information
12.9.2 Medtronic Description and Business Overview
12.9.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Medtronic Spinal Devices and Biologics Products Offered
12.9.5 Medtronic Recent Development
12.10 Alphatec Holdings
12.10.1 Alphatec Holdings Corporation Information
12.10.2 Alphatec Holdings Description and Business Overview
12.10.3 Alphatec Holdings Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Alphatec Holdings Spinal Devices and Biologics Products Offered
12.10.5 Alphatec Holdings Recent Development
12.11 Nuvasive
12.11.1 Nuvasive Corporation Information
12.11.2 Nuvasive Description and Business Overview
12.11.3 Nuvasive Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Nuvasive Spinal Devices and Biologics Products Offered
12.11.5 Nuvasive Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Spinal Devices and Biologics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Spinal Devices and Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Spinal Devices and Biologics Market Segments
Table 2. Ranking of Global Top Spinal Devices and Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Spinal Devices and Biologics Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Spinal Fusion & Fixation
Table 5. Major Manufacturers of Motion Preservation
Table 6. Major Manufacturers of Non-Fusion Technologies
Table 7. Major Manufacturers of Fracture Treatment
Table 8. Major Manufacturers of Other
Table 9. Global Spinal Devices and Biologics Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Spinal Devices and Biologics Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Spinal Devices and Biologics Sales by Regions 2015-2020 (K Units)
Table 12. Global Spinal Devices and Biologics Sales Market Share by Regions (2015-2020)
Table 13. Global Spinal Devices and Biologics Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Spinal Devices and Biologics Sales Forecast by Region (2021-2026) (K Units)
Table 15. Global Spinal Devices and Biologics Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Spinal Devices and Biologics Sales Share by Manufacturers (2015-2020)
Table 17. Global Spinal Devices and Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Spinal Devices and Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal Devices and Biologics as of 2019)
Table 19. Spinal Devices and Biologics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Spinal Devices and Biologics Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Spinal Devices and Biologics Price (2015-2020) (USD/Unit)
Table 22. Spinal Devices and Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Spinal Devices and Biologics Product Type
Table 24. Date of International Manufacturers Enter into Spinal Devices and Biologics Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Devices and Biologics Sales by Type (2015-2020) (K Units)
Table 27. Global Spinal Devices and Biologics Sales Share by Type (2015-2020)
Table 28. Global Spinal Devices and Biologics Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Spinal Devices and Biologics Revenue Share by Type (2015-2020)
Table 30. Spinal Devices and Biologics Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Spinal Devices and Biologics Sales Share by Type (2021-2026)
Table 32. Global Spinal Devices and Biologics Sales by Application (2015-2020) (K Units)
Table 33. Global Spinal Devices and Biologics Sales Share by Application (2015-2020)
Table 34. Global Spinal Devices and Biologics Sales Share by Application (2021-2026)
Table 35. Global Spinal Devices and Biologics Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Spinal Devices and Biologics Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Spinal Devices and Biologics Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan Spinal Devices and Biologics Sales (K Units) of Key Companies (2015-2020)
Table 39. Japan Spinal Devices and Biologics Sales Share by Company (2015-2020)
Table 40. Japan Spinal Devices and Biologics Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan Spinal Devices and Biologics Sales (K Units) by Type (2015-2020)
Table 42. Japan Spinal Devices and Biologics Sales Share by Type (2015-2020)
Table 43. Japan Spinal Devices and Biologics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan Spinal Devices and Biologics Price (K Units) by Type (2015-2020)
Table 45. Japan Spinal Devices and Biologics Sales (K Units) by Type (2021-2026)
Table 46. Japan Spinal Devices and Biologics Sales Share by Type (2021-2026)
Table 47. Japan Spinal Devices and Biologics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan Spinal Devices and Biologics Revenue Share by Type (2021-2026)
Table 49. Japan Spinal Devices and Biologics Price (K Units) by Type (2021-2026)
Table 50. Japan Spinal Devices and Biologics Sales (K Units) by Application (2015-2020)
Table 51. Japan Spinal Devices and Biologics Sales Share by Application (2015-2020)
Table 52. Japan Spinal Devices and Biologics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan Spinal Devices and Biologics Sales (K Units) by Application (2021-2026)
Table 54. Japan Spinal Devices and Biologics Sales Share by Application (2021-2026)
Table 55. Japan Spinal Devices and Biologics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan Spinal Devices and Biologics Revenue Share by Application (2021-2026)
Table 57. North America Spinal Devices and Biologics Sales by Country (2015-2020) (K Units)
Table 58. North America Spinal Devices and Biologics Sales Market Share by Country (2015-2020)
Table 59. North America Spinal Devices and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Spinal Devices and Biologics Revenue Market Share by Country (2015-2020)
Table 61. Europe Spinal Devices and Biologics Sales by Country (2015-2020) (K Units)
Table 62. Europe Spinal Devices and Biologics Sales Market Share by Country (2015-2020)
Table 63. Europe Spinal Devices and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Spinal Devices and Biologics Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Spinal Devices and Biologics Sales by Region (2015-2020) (K Units)
Table 66. Asia Pacific Spinal Devices and Biologics Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Spinal Devices and Biologics Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Spinal Devices and Biologics Revenue Market Share by Region (2015-2020)
Table 69. Latin America Spinal Devices and Biologics Sales by Country (2015-2020) (K Units)
Table 70. Latin America Spinal Devices and Biologics Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Spinal Devices and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Spinal Devices and Biologics Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Spinal Devices and Biologics Sales by Country (2015-2020) (K Units)
Table 74. Middle East and Africa Spinal Devices and Biologics Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Spinal Devices and Biologics Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Spinal Devices and Biologics Revenue Market Share by Country (2015-2020)
Table 77. Nuvasive Corporation Information
Table 78. Nuvasive Description and Business Overview
Table 79. Nuvasive Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Nuvasive Spinal Devices and Biologics Product
Table 81. Nuvasive Recent Development
Table 82. Orthofix International Corporation Information
Table 83. Orthofix International Description and Business Overview
Table 84. Orthofix International Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Orthofix International Product
Table 86. Orthofix International Recent Development
Table 87. Exactech Corporation Information
Table 88. Exactech Description and Business Overview
Table 89. Exactech Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Exactech Product
Table 91. Exactech Recent Development
Table 92. Wright Medical Group Corporation Information
Table 93. Wright Medical Group Description and Business Overview
Table 94. Wright Medical Group Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Wright Medical Group Product
Table 96. Wright Medical Group Recent Development
Table 97. Johnson & Johnson Corporation Information
Table 98. Johnson & Johnson Description and Business Overview
Table 99. Johnson & Johnson Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Johnson & Johnson Product
Table 101. Johnson & Johnson Recent Development
Table 102. Zimmer Biomet Corporation Information
Table 103. Zimmer Biomet Description and Business Overview
Table 104. Zimmer Biomet Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Zimmer Biomet Product
Table 106. Zimmer Biomet Recent Development
Table 107. Globus Medical Corporation Information
Table 108. Globus Medical Description and Business Overview
Table 109. Globus Medical Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Globus Medical Product
Table 111. Globus Medical Recent Development
Table 112. K2M Corporation Information
Table 113. K2M Description and Business Overview
Table 114. K2M Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. K2M Product
Table 116. K2M Recent Development
Table 117. Medtronic Corporation Information
Table 118. Medtronic Description and Business Overview
Table 119. Medtronic Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Medtronic Product
Table 121. Medtronic Recent Development
Table 122. Alphatec Holdings Corporation Information
Table 123. Alphatec Holdings Description and Business Overview
Table 124. Alphatec Holdings Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Alphatec Holdings Product
Table 126. Alphatec Holdings Recent Development
Table 127. RTI Surgical Corporation Information
Table 128. RTI Surgical Description and Business Overview
Table 129. RTI Surgical Spinal Devices and Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. RTI Surgical Product
Table 131. RTI Surgical Recent Development
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Spinal Devices and Biologics Players
Table 136. Spinal Devices and Biologics Customers List
Table 137. Spinal Devices and Biologics Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of FiguresFigure 1. Spinal Devices and Biologics Product Picture
Figure 2. Global Spinal Devices and Biologics Sales Market Share by Type in 2020 & 2026
Figure 3. Spinal Fusion & Fixation Product Picture
Figure 4. Motion Preservation Product Picture
Figure 5. Non-Fusion Technologies Product Picture
Figure 6. Fracture Treatment Product Picture
Figure 7. Other Product Picture
Figure 8. Global Spinal Devices and Biologics Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Ambulatory Surgical Centers
Figure 11. Clinics
Figure 12. Other
Figure 13. Spinal Devices and Biologics Report Years Considered
Figure 14. Global Spinal Devices and Biologics Market Size 2015-2026 (US$ Million)
Figure 15. Global Spinal Devices and Biologics Sales 2015-2026 (K Units)
Figure 16. Global Spinal Devices and Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Spinal Devices and Biologics Sales Market Share by Region (2015-2020)
Figure 18. Global Spinal Devices and Biologics Sales Market Share by Region in 2019
Figure 19. Global Spinal Devices and Biologics Revenue Market Share by Region (2015-2020)
Figure 20. Global Spinal Devices and Biologics Revenue Market Share by Region in 2019
Figure 21. Global Spinal Devices and Biologics Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Spinal Devices and Biologics Revenue in 2019
Figure 23. Spinal Devices and Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Spinal Devices and Biologics Sales Market Share by Type (2015-2020)
Figure 25. Global Spinal Devices and Biologics Sales Market Share by Type in 2019
Figure 26. Global Spinal Devices and Biologics Revenue Market Share by Type (2015-2020)
Figure 27. Global Spinal Devices and Biologics Revenue Market Share by Type in 2019
Figure 28. Global Spinal Devices and Biologics Market Share by Price Range (2015-2020)
Figure 29. Global Spinal Devices and Biologics Sales Market Share by Application (2015-2020)
Figure 30. Global Spinal Devices and Biologics Sales Market Share by Application in 2019
Figure 31. Global Spinal Devices and Biologics Revenue Market Share by Application (2015-2020)
Figure 32. Global Spinal Devices and Biologics Revenue Market Share by Application in 2019
Figure 33. Japan Spinal Devices and Biologics Sales Growth Rate 2015-2026 (K Units)
Figure 34. Japan Spinal Devices and Biologics Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. Japan Spinal Devices and Biologics Market Share in Global Market 2015-2026
Figure 36. Japan 5 and 10 Largest Spinal Devices and Biologics Players Market Share by Revenue in Spinal Devices and Biologics in 2019
Figure 37. Japan Spinal Devices and Biologics Revenue Share by Type (2015-2020)
Figure 38. Japan Spinal Devices and Biologics Revenue Growth Rate by Type in 2015 & 2019
Figure 39. Japan Spinal Devices and Biologics Revenue Share by Application (2015-2020)
Figure 40. Japan Spinal Devices and Biologics Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Spinal Devices and Biologics Sales Growth Rate 2015-2020 (K Units)
Figure 42. North America Spinal Devices and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Spinal Devices and Biologics Sales Market Share by Country in 2019
Figure 44. North America Spinal Devices and Biologics Revenue Market Share by Country in 2019
Figure 45. U.S. Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 46. U.S. Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 48. Canada Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Spinal Devices and Biologics Sales Growth Rate 2015-2020 (K Units)
Figure 50. Europe Spinal Devices and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Spinal Devices and Biologics Sales Market Share by Country in 2019
Figure 52. Europe Spinal Devices and Biologics Revenue Market Share by Country in 2019
Figure 53. Germany Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 54. Germany Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 56. France Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 58. U.K. Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 60. Italy Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 62. Russia Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Spinal Devices and Biologics Sales Growth Rate 2015-2020 (K Units)
Figure 64. Asia Pacific Spinal Devices and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Spinal Devices and Biologics Sales Market Share by Region in 2019
Figure 66. Asia Pacific Spinal Devices and Biologics Revenue Market Share by Region in 2019
Figure 67. China Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 68. China Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 70. Japan Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 72. South Korea Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 74. India Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 76. Australia Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 78. Taiwan Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 80. Indonesia Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 82. Thailand Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 84. Malaysia Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 86. Philippines Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 88. Vietnam Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Spinal Devices and Biologics Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America Spinal Devices and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Spinal Devices and Biologics Sales Market Share by Country in 2019
Figure 92. Latin America Spinal Devices and Biologics Revenue Market Share by Country in 2019
Figure 93. Mexico Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 98. Argentina Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Spinal Devices and Biologics Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Spinal Devices and Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Spinal Devices and Biologics Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Spinal Devices and Biologics Revenue Market Share by Country in 2019
Figure 103. Turkey Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Spinal Devices and Biologics Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Spinal Devices and Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. Spinal Devices and Biologics Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This